FIELD: medicine; ultrasound diagnostics.
SUBSTANCE: invention can be used for ultrasound diagnostics of obesity. To achieve this, an ultrasound examination is carried out in five successive stages. The patient is placed in a supine position. At the first stage, epicardial fat tissue is examined. At the second stage, minimum thickness of subcutaneous fatty tissue and the maximum thickness of preparietal fatty tissue are examined. At the third stage subcutaneous fatty tissue at the navel level is examined. At the fourth stage, visceral abdominal tissue is measured. At the fifth stage, the perinephric retroperitoneal tissue is examined. After a comprehensive ultrasound examination, a conclusion is made about the absence of both visceral and parietal obesity, the presence of visceral or parietal obesity, or the mixed type, in which both the presence of visceral and parietal obesity is observed. In the absence of visualized epicardial fatty tissue or the presence of a thickness of epicardial fatty tissue measuring less than or equal to 5 mm, with a thickness of subcutaneous fatty tissue measuring less than 11 mm at the point under the xiphoid process, with preparietal fatty tissue measuring less than 8 mm, with a thickness of subcutaneous fatty tissue less than 17 mm in the peri-umbilical region, with a thickness of visceral abdominal tissue less than 5 mm in the peri-renal zone, it is concluded that there is no either visceral or parietal obesity. When the thickness of epicardial fatty tissue is determined to be more than 5 mm in size and when the thickness of visceral abdominal fat is more than 5 mm in the perinephric zone, visceral obesity is diagnosed. Parietal obesity is diagnosed in the case of the absence of visualized epicardial fatty tissue or the presence of epicardial fatty tissue thickness less than or equal to 5 mm, with a subcutaneous fatty tissue thickness of more than 11 mm at the point under the xiphoid process, with a preparietal fatty tissue thickness of more than 8 mm, with a subcutaneous fatty tissue thickness fatty tissue more than 17 mm in the peri-umbilical region, with a thickness of visceral abdominal tissue less than 5 mm in the perirenal zone. A mixed type of obesity is diagnosed in the following cases: the thickness of the epicardial fatty tissue is more than 5 mm, the thickness of the subcutaneous fatty tissue is more than 11 mm at the point under the xiphoid process, the thickness of the preparietal fatty tissue is more than 8 mm, the thickness of the subcutaneous fatty tissue is more than 17 mm in the periumbilical region, when the thickness of the visceral abdominal tissue is more than 5 mm in the perinephric zone.
EFFECT: invention provides an objective diagnosis of obesity, establishing the exact localization of an increase in adipose tissue.
3 cl, 18 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING OBESITY | 2023 |
|
RU2812582C1 |
METHOD FOR ULTRASOUND DIAGNOSTICS OF METABOLIC PHENOTYPE OF ABDOMINAL OBESITY | 2020 |
|
RU2751972C1 |
ULTRASONIC METHOD OF DETERMINING THICKNESS OF ADIPOSE TISSUE IN ABDOMINAL AREA | 2012 |
|
RU2525664C1 |
METHOD OF ULTRASONIC DIAGNOSTICS OF VISCERAL OBESITY | 2009 |
|
RU2407440C1 |
METHOD OF DIAGNOSTICS OF METABOLIC SYNDROME BY ULTRASONIC LIPOMETRY | 2017 |
|
RU2677526C1 |
METHOD FOR PREVENTION OF POSTOPERATIVE VENTRAL HERNIAS AFTER MEDIAL LAPAROTOMY | 2019 |
|
RU2716620C1 |
METHOD OF ULTRASONIC DIAGNOSTICS OF RETROPERITONEAL VISCERAL OBESITY | 2018 |
|
RU2699727C2 |
METHOD FOR ULTRASOUND DIAGNOSTICS OF UNDIFFERENTIATED FORMS OF CONNECTIVE TISSUE DYSPLASIA | 2020 |
|
RU2780923C2 |
METHOD FOR REMOVING TUMOR OF RIGHT-HAND ADRENAL GLAND | 2004 |
|
RU2285461C2 |
METHOD OF COMBINED SURGICAL MANAGEMENT OF IA-IB ENDOMETRIAL CANCER IN PATIENTS WITH MORBID OBESITY | 2019 |
|
RU2722566C2 |
Authors
Dates
2023-10-02—Published
2022-06-23—Filed